Hong Kong Pharmaceuticals and Healthcare Report - Business Monitor International - Industry Reports

Hong Kong Pharmaceuticals and Healthcare Report

Hong Kong Pharmaceuticals and Healthcare Report - Business Monitor International - Industry Reports
Hong Kong Pharmaceuticals and Healthcare Report
Published Oct 08, 2016
96 pages — Published Oct 08, 2016
Price US$ 1,295.00  |  Buy this Report Now

About This Report

  
Abstract:

In July ----, the government was unable to take a final vote on a bill seeking to reform the Medical Council. Doctors had rallied against the bill, complaining about a lack of public consultation and government interference. ...Depending on the sale restriction, there are specific labelling requirements. In August ----, local news sources reported that the Centre for Health Protection was investigating a confirmed case of dengue which physicians note might be the first locally acquired case of the year. As of August - ----, there were -- reported dengue fever and in ----, there were a total of --- reported incidents of the virus. ...In August ----, local news sources reported that the Centre for Health Protection was investigating a confirmed case of dengue which physicians note might be the first locally acquired case of the year. As of August - ----, there were -- reported dengue fever and in ----, there were a total of --- reported incidents of the virus.

...Criticism of the Hospital Authority s procurement methods. Approval of locally produced generic drugs without referral to the original product patent. ...Local manufacturing sector output mainly comprised of cheap, basic medicines. Market highly reliant on imports - particularly at the high-tech end of the scale - which places considerable pressure on government healthcare finances. Counterfeiting and regulatory shortcomings present problems for the legitimate pharmaceutical market. ...Market highly reliant on imports - particularly at the high-tech end of the scale - which places considerable pressure on government healthcare finances. Counterfeiting and regulatory shortcomings present problems for the legitimate pharmaceutical market.

...BMI View: Hong Kong will increase its reliance on generic drugs on the back of rising expenditure and an ageing population. In line with this, pharmaceutical expenditure will progressively rise. ...

  
Source:
Document ID
1748-1910
Country
Industry
Format:
PDF Adobe Acrobat
Buy Now

Business Monitor International - Industry Reports—Established in 1984, Business Monitor International is a leading online publisher of specialist business information on global emerging markets. Business Monitor's range of quarterly services covers political risk, finance, macroeconomic performance, outlook and forecast, industry sectors and the business operating environment. Each Industry Report has been researched at source, and features latest-available data covering production, sales, imports and exports; 5-year industry forecasts through end-2012; company rankings and competitive landscapes for multinational and local manufacturers and suppliers; and analysis of latest industry developments, trends and regulatory changes.

About the Author


Cite this Report

  
MLA:
Business Monitor International - Industry Reports. "Hong Kong Pharmaceuticals and Healthcare Report" Oct 08, 2016. Alacra Store. Dec 04, 2016. <http://www.alacrastore.com/storecontent/Business-Monitor-International-Industry-Reports/Hong-Kong-Pharmaceuticals-and-Healthcare-Report-2026-113>
  
APA:
Business Monitor International - Industry Reports. (2016). Hong Kong Pharmaceuticals and Healthcare Report Oct 08, 2016. New York, NY: Alacra Store. Retrieved Dec 04, 2016 from <http://www.alacrastore.com/storecontent/Business-Monitor-International-Industry-Reports/Hong-Kong-Pharmaceuticals-and-Healthcare-Report-2026-113>
  
US$ 1,295.00
$  £  
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our Market Research from one place.